Skip to main content
SpringerLink
Log in

Infarktbedingter kardiogener Schock

Diagnose, Monitoring und Therapie

Cardiogenic shock due to infarction

Diagnosis, monitoring, and treatment

  • Leitthema
  • Published:
Notfall + Rettungsmedizin Aims and scope Submit manuscript

Zusammenfassung

Der kardiogene Schock ist die häufigste Todesursache beim akuten Myokardinfarkt. Die Sterblichkeit liegt bei 50–80%. Der kardiogene Schock ist durch eine kritische Verminderung der kardialen Pumpleistung mit Hypoperfusion und inadäquater Sauerstoffversorgung der peripheren Organe gekennzeichnet. Die Diagnose „infarktbedingter kardiogener Schock“ wird anhand klinischer und hämodynamischer Kriterien gestellt. Rasche diagnostische und therapeutische Maßnahmen können die Todesspirale des kardiogenen Schocks positiv beeinflussen. Wichtig sind in diesem Zusammenhang die schnelle Reperfusion der Infarktarterie und eine effektive hämodynamische Stabilisierung durch die medikamentöse Therapie.

Abstract

Cardiogenic shock is the most frequent cause of death in cases of acute myocardial infarction. The mortality rate is 50–80%. Cardiogenic shock is characterized by critical reduction of cardiac pumping capacity with hypoperfusion and inadequate oxygen supply to the peripheral organs. The diagnosis of “cardiogenic shock due to infarction” is reached based on clinical and hemodynamic criteria. Rapid initiation of diagnostic and therapeutic measures can have a positive effect on the deathly spiral of cardiogenic shock. In this context, prompt reperfusion of the infarcted artery and effective hemodynamic stabilization with drug therapy are important.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Anderson RD, Ohman EM, Holmes DR Jr et al. (1997) Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. J Am College Cardiol 30: 708–715

    Article  Google Scholar 

  2. Buerke M, Murohara T, Skurk C et al. (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92: 8031–8035

    Article  PubMed  Google Scholar 

  3. Buerke M, Schwertz H, Seitz W et al. (2001) Novel small molecule Inhibitor of C1 s exerts cardioprotective effects in ischemia-reperfusion Injury in rabbits. J Immunol 167: 5375–5380

    PubMed  Google Scholar 

  4. Chanques G, Jaber S, Barbotte E et al. (2006) Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med 34: 1691–1699

    Article  PubMed  Google Scholar 

  5. Chen EW, Canto JG, Parsons LS et al. (2003) Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 108: 951–957

    Article  PubMed  Google Scholar 

  6. Cotter G, Kaluski E, Milo O et al. (2003) LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 24: 1287–1295

    Article  PubMed  Google Scholar 

  7. Cotter G, Williams SG, Vered Z, Tan LB (2003b) Role of cardiac power in heart failure. Curr Opin Cardiol 18: 215–222

    Article  PubMed  Google Scholar 

  8. Cuffe MS, Califf RM, Adams KF et al. (2002) Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287: 1541–1547

    Article  PubMed  Google Scholar 

  9. Delle Karth G, Buberl A, Geppert A et al. (2003) Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 47: 1251–1256

    Article  PubMed  Google Scholar 

  10. Durrer JD, Lie KI, van Capelle FJ, Durrer D (1982) Effect of sodium nitroprusside on mortality in acute myocardial infarction. N Engl J Med 306: 1121–1128

    PubMed  Google Scholar 

  11. Field S, Kelly SM, Macklem PT (1982) The oxygen cost of breathing in patients with cardiorespiratory disease. Am Rev Respir Dis 126: 9–13

    PubMed  Google Scholar 

  12. Fincke R, Hochman JS, Lowe AM et al. (2004) Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am College Cardiol 44: 340–348

    Article  Google Scholar 

  13. Friedrich JO, Adhikari N, Herridge MS, Beyene J (2005) Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142: 510–524

    PubMed  Google Scholar 

  14. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Ferrer-Hita JJ et al. (in press) Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Failure (corrected proof)

  15. Granger CB, Mahaffey KW, Weaver WD et al. (2003) Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 108: 1184–1190

    Article  PubMed  Google Scholar 

  16. Heer T, Zeymer U, Juenger C et al. (2006) Beneficial effects of abciximab in patients with primary percutaneous intervention for acute st segment elevation myocardial infarction in clinical practice. Heart, hrt.2005.085456

  17. Hochman JS, Boland J, Sleeper LA et al. (1995) Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 91: 873–881

    PubMed  Google Scholar 

  18. Hochman JS, Sleeper LA, Webb JG et al. (2006) Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295: 2511–2515

    Article  PubMed  Google Scholar 

  19. Hochman JS, Sleeper LA, Webb JG et al. (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341: 625–634

    Article  PubMed  Google Scholar 

  20. Hochman JS, Sleeper LA, White HD et al. (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285: 190–192

    Article  PubMed  Google Scholar 

  21. Jolly S, Newton G, Horlick E et al. (2005) Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 96: 1617–1620

    Article  PubMed  Google Scholar 

  22. Metra M, Nodari S, Aloia A et al. (2002) Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. J Am College Cardiol 40: 1248–1258

    Article  Google Scholar 

  23. Ohman EM, Nanas J, Stomel RJ et al. (2005) Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 19: 33–39

    Article  PubMed  Google Scholar 

  24. Rudiger A, Gasser S, Fischler M et al. (2006) Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med (in press)

  25. Ruß M, Prondzinsky R, Reith S et al. (2005) Profound hemodynamic improvement following levosimendan in patients with acute myocardial infarction and severe cardiogenic shock. Circulation Suppl 112: 11–423

    Article  Google Scholar 

  26. Sanborn TA, Sleeper LA, Webb JG et al. (2003) Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol 42: 1373–1379

    Article  PubMed  Google Scholar 

  27. Slater J, Brown RJ, Antonelli TA et al. (2000) Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36: 1117–1122

    Article  PubMed  Google Scholar 

  28. White HD, Assmann SF, Sanborn TA et al. (2005) Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial. Circulation 112: 1992–2001

    Article  PubMed  Google Scholar 

  29. Zion MM, Balkin J, Rosenmann D et al. (1990) Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5,841 patients in the SPRINT Registry. SPRINT Study Group. Chest 98: 1331–1335

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf eine Verbindung mit folgender Firma/Firmen hin: Referententätigkeit für Datascope, Abbott. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.

Author information

Authors and Affiliations

  1. Universitätsklinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06097 , Halle/Saale, Deutschland

    M. Buerke, M. Ruß & K. Werdan

Authors
  1. M. Buerke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ruß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Werdan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Buerke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buerke, M., Ruß, M. & Werdan, K. Infarktbedingter kardiogener Schock. Notfall Rettungsmed 9, 522–528 (2006). https://doi.org/10.1007/s10049-006-0854-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10049-006-0854-7

Schlüsselwörter

Keywords

Search

Navigation